Protagonist Therapeutics, Inc (PTGX) › Operating IncomeProtagonist Therapeutics, Inc (PTGX) — Operating IncomeAnnual figures by period end, from SEC filings.2014-12-31: -$9.32M2015-12-31: -$14.79M2016-12-31: -$32.67M2017-12-31: -$37.90M2018-12-31: -$42.27M2019-12-31: -$80.52M2020-12-31: -$64.52M2021-12-31: -$125.84M2022-12-31: -$131.37M2023-12-31: -$93.65M2024-12-31: $252.84M2025-12-31: -$158.13M-$158.13M2014-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$158.13M-162.5%2026-02-25From 2025-01-012024-12-31$252.84M—2026-02-25From 2024-01-012023-12-31-$93.65M—2026-02-25From 2023-01-012022-12-31-$131.37M—2025-02-21From 2022-01-012021-12-31-$125.84M—2024-02-27From 2021-01-012020-12-31-$64.52M—2023-03-15From 2020-01-012019-12-31-$80.52M—2022-02-28From 2019-01-012018-12-31-$42.27M—2021-03-10From 2018-01-012017-12-31-$37.90M—2020-03-10From 2017-01-012016-12-31-$32.67M—2019-03-12From 2016-01-012015-12-31-$14.79M—2018-03-07From 2015-01-012014-12-31-$9.32M—2017-03-07From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)